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Single nucleotide polymorphisms (SNPs) have been increasingly utilized to investigate somatic genetic abnormalities
in premalignancy and cancer. LOH is a common alteration observed during cancer development, and SNP assays have
been used to identify LOH at specific chromosomal regions. The design of such studies requires consideration of the
resolution for detecting LOH throughout the genome and identification of the number and location of SNPs required to
detect genetic alterations in specific genomic regions. Our study evaluated SNP distribution patterns and used
probability models, Monte Carlo simulation, and real human subject genotype data to investigate the relationships
between the number of SNPs, SNP HET rates, and the sensitivity (resolution) for detecting LOH. We report that
variances of SNP heterozygosity rate in dbSNP are high for a large proportion of SNPs. Two statistical methods
proposed for directly inferring SNP heterozygosity rates require much smaller sample sizes (intermediate sizes) and are
feasible for practical use in SNP selection or verification. Using HapMap data, we showed that a region of LOH greater
than 200 kb can be reliably detected, with losses smaller than 50 kb having a substantially lower detection probability
when using all SNPs currently in the HapMap database. Higher densities of SNPs may exist in certain local
chromosomal regions that provide some opportunities for reliably detecting LOH of segment sizes smaller than 50 kb.
These results suggest that the interpretation of the results from genome-wide scans for LOH using commercial arrays
need to consider the relationships among inter-SNP distance, detection probability, and sample size for a specific
study. New experimental designs for LOH studies would also benefit from considering the power of detection and
sample sizes required to accomplish the proposed aims.
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Introduction
Single nucleotide polymorphisms (SNPs) are common DNA
sequence variations and have been widely investigated for
their roles in disease causation [1] or association [2,3],
heterogeneous responses to drug therapies [4–6], genetic
linkage analysis [7,8], and evolutionary biology [9,10]. This has
led to the characterization of whole-genome patterns of a
large number of common SNPs in a few ethnic groups [11].
Distinct from constitutive genome studies, SNPs have also
been used extensively to study the somatic development of
cancer [12] (also see review by Engle, et al. [13]). Alterations of
the copy number of DNA sequences (DNA ampliﬁcation or
deletion) and those that result in a loss of genetic information
(loss of heterozygosity; LOH) occur frequently in neoplastic
tissues and tumors, and changes in the copy number or
heterozygosity of SNPs allow these alterations to be detected
and mapped in the genome. Low density, whole genome
analyses have previously been sufﬁcient to allow gross
characterization of critical genetic alterations that occur
during neoplastic progression. However, much ﬁner-scale
mapping of these alterations is frequently required both for
furthering basic understanding of the genetic events that
occur during progression to cancer and for developing
diagnostic tests with sufﬁcient sensitivity and speciﬁcity for
translation into clinical practice. In addition, commercial
high-density SNP platforms tend to be both expensive and
biospecimen-intensive, making them impractical for high-
throughput, ﬁne-scale mapping of speciﬁc chromosomal
regions. The alternative is to develop a custom panel of
SNPs that can characterize the genomic region of interest.
Detection of LOH requires SNPs to be heterozygous (i.e.,
informative). In the largest public SNP database, dbSNP
(http://www.ncbi.nlm.nih.gov/SNP), the heterozygosity (HET)
rates estimated for a substantial number of SNPs have large
estimated variances, likely due to small sample sizes, among
other reasons [14]. Using SNPs with large HET rates variances
may lead to ambiguous experimental results (e.g., an under-
powered study). A better understanding of how the distribu-
tion of SNPs in the genome and the variance of SNP HET
rates affect the ability of a panel of SNPs to detect LOH
would allow improved design of SNP-based assays for somatic
genetic alteration studies. Statistical models for classifying
subjects by LOH proﬁle that take into account noninforma-
tive markers have been developed [15]. We used real genotype
data to investigate the relationship between detection
probabilities (resolution) and LOH sizes using all currently
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related to sample size and power calculations in LOH
detection experimental design. As well, the study evaluates
the key factors governing the selection of a group of SNPs for
designing custom assays for particular chromosomal regions.
Speciﬁcally, we ﬁrst evaluated the variances in SNP HET rate
estimation currently reported in the dbSNP database, and
then addressed sample size issues related to directly inferring
SNP HET rates for the purpose of selecting SNPs for LOH
detection. We propose two statistical approaches to deter-
mine the minimum number of individuals in a population
that would need to be examined to determine if a SNP HET
rate was above or below a speciﬁed threshold. Finally, we
evaluate the relationships between the number of SNPs, SNP
HET rates, and sensitivity (resolution) for detecting LOH
using real whole-genome genotype data.
Results
The frequency distribution of the average SNP HET rates
for each SNP reported in the dbSNP database is shown in
Figure 1. The genome-wide mean HET rate is 0.263 (SD ¼
0.171). The observed pattern was similar to a beta distribu-
tion, although the data do not exactly ﬁt a formal beta
distribution. Figure 2 shows the distribution of the estimated
coefﬁcient of variation (CV ¼ SD/Mean%) of SNP HET rates
in the dbSNP database.
These results indicate that a signiﬁcant number of the SNPs
in dbSNP have large estimated variances, which would not
provide enough precise information for designing studies
requiring the accurate estimation of SNP HET rates (i.e.,
those using SNPs for LOH detection for molecular diag-
noses). Traditionally, for diallelic alleles with p1 and p2 allele
frequencies, the HET rate could be estimated as hr ¼ 2p1p2,
although this formula is appropriate only for alleles in HWE.
Another approach, which is robust to HWE assumptions, is to
estimate the HET rate (and its variance) directly by
population allele frequencies [16]. This method requires
large sample sizes in order to achieve accurate estimation of
HET rates. Here we consider the case where the HET rate is
measured directly using techniques like DNA sequencing,
microarray analysis, Pyrosequencing, or MALDI-TOF.
Using hypothetical parameters for true HET rates and
sample sizes, we ﬁrst show the relationships among true HET
rates, estimated HET rates, their estimated variances, and
sample sizes using the score method with continuity
correction (exact binomial method may result in larger CI)
(Table 1). The variance of HET rates could be estimated by
(hr(1   hr))/(N   1), where N is the sample size. Table 1 shows
that even with moderately large sample size (e.g., N¼100), the
conﬁdence interval or CVs are quite large for all values of
HET rates listed, particularly for lower HET rates (some
upper bounds of the CI even exceeded the theoretical
maximum value of hr ¼ 0.5). With 500 subjects tested, the
estimated CI and variance are small, but such a sample size is
prohibitively large for many studies.
We introduce two different approaches to deal with the
unrealistically large sample size requirement. In using SNPs
to evaluate LOH in a speciﬁc chromosomal region, it is
desirable that the HET rates of selected SNPs used in the
region be higher than a speciﬁc value to increase the
probability that at least one SNP will be informative for each
patient. Therefore, the question is to test the statistical
hypothesis for the HET rate of a speciﬁc SNP hrs versus a
prespeciﬁed HET rate value hr0 (i.e., H0: hr   hr0 versus H1: hr
, hr0). With a given power and sample size n, we have:
PfReject H0jhr ¼ hrsg¼P Z,
hr0   hrs þ Za
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
hr0ð1   hr0Þ=n
p
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
hrsð1   hrsÞ=n
p
()
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To get sample size, we have:
ðhr0 hrsÞ Za
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Za and Zb are the 100(1 a)th and 100(1 b)th percentile of the
standard normal distribution.
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Figure 1. Frequency Distribution Pattern of Estimated Average SNP HET
Rates in the dbSNP Database
Blue bars are the distribution of SNP HET rates in dbSNP; red line is fitted
line. Chi-square goodness of fit test (with 20 bins) for fitting a beta
distribution was not rejected at a ¼ 0.01 level.
doi:10.1371/journal.pcbi.0030244.g001
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Author Summary
More than 99% of each person’s genome is identical to everyone
else’s. Many of the differences involve single base pairs, termed
single nucleotide polymorphisms (SNPs). SNPs are used as genetic
markers to facilitate identification of disease-causing genes, as well
as in cancer studies by aiding in determining which regions of the
genome may be lost (LOH) or amplified during neoplastic
progression. One drawback to SNPs is their low informativity: a
SNP is only informative if it is polymorphic on the two different
alleles found on each chromosome of a pair; and if there is not an
informative SNP in the region of genome of interest, it is impossible
to detect alterations occurring there through LOH. A common
solution to this problem is to use arrays containing hundreds of
thousands of SNPs to ensure adequate coverage, but for many
studies this is prohibitive on a cost and sample amount basis. In
addition, SNP distribution itself can constrain the size of loss that
can be reliably detected at the population level. We examined the
relationship between chromosome loss sizes and detection prob-
ability of LOH genome-wide. The study provides useful information
for researchers designing LOH-related studies and evaluating results
obtained from such studies.
SNP Heterozygosity Rates and LOH DetectionUsing Equation 1, Table 2 shows the sample sizes needed
for testing whether the HET rate of a given SNP is
signiﬁcantly higher than a desired threshold. The sample size
required to reject H0 is reasonably small in most cases; e.g.,
when hr0 ¼ 0.2, and hrs ¼ 0.35, only 50–72 subjects need to be
tested. However, when a SNP HET rate hrs is near the desired
threshold value hr0, the required sample size becomes much
larger.
Table 2 utilizes a ﬁxed sample size method that is easy to
use, but may not be optimal when considering the number of
subjects needed. A sequential sampling technique based on
the sequential probability ratio test (SPRT) [17] can be used
for directly inferring SNP heterozygous rates. With this
method, samples are tested one by one and a decision will be
made to determine whether or not the HET rate of a SNP has
reached a prespeciﬁed value after each sample is tested. This
method generally requires less time and reagents and
conserves biospecimens that are frequently unique and
difﬁcult to obtain. Speciﬁcally, SPRT tests the SNP HET rate
h using the hypothesis H0:h¼ h0 versus H1:h¼ h1,( h1 , h0).
The likelihood ratio is
kðx1;:::;xn;h0;h1Þ¼
Pðm heterozygous in n observationsjh ¼ h1Þ
Pðm heterozygous in n observationsjh ¼ h0Þ
¼
hm
1ð1   h1Þ
n m
hm
0ð1   h0Þ
n m :
For type I error (false positive) level a, and type II error
(false negative) level b, (power ¼ 1   b ), it has been shown
that sample testing should continue if ln
b
1 a
  
, ln(k(x1, ...,
xn,h 0,h 1)) , ln
1 b
a
  
;i fln(k) reaches or passes beyond the
two bounds, then sample testing should stop. The hypothesis
H0 will be accepted when ln
b
1 a
  
  ln(k), or H0 will
be rejected and H1 accepted when ln(k)   ln
1 b
a
  
. In this
process, the total number of samples tested is a random
variable based on the distribution speciﬁed by parameters
h0, h1, a, b, and the underlying HET rate h of a speciﬁc SNP.
In the SPRT approach, for ﬁxed h, a, and b, the ASN
(average sample number) depends on h0 and h1. Table 3
shows simulation results for testing h0 ¼ 0.3, and h1 ¼ 0.2
against various true (sample) SNP HET rates h. For example,
if the true SNP HET rates under testing are h ¼ 0.4 or above,
approximately 15 to 40 subjects need to be tested, on
average, to make a decision on whether h ¼ h0, and, under
the most optimistic situations, only four subjects are
necessary to determine the HET rate regarding hypothesis
H0. Depending on the goals of a study, the SPRT method
could be used to signiﬁcantly reduce the testing sample size
required for SNP HET rate inference (e.g., compare to
values in Table 1).
We also examined the number of SNPs needed for reliable
detection of LOH for random chromosomal regions of a
speciﬁc length assuming the SNP HET rate distribution
shown in Figure 1. If SNPs are being used to effectively detect
the loss of a chromosomal segment, the segment should
Table 1. Relationship between Sample Size and Estimation of SNP Heterozygous Rates
True HET
Rate (hr)
Sample
Size
Expected Number
of Heterozygous
Estimated 95%
CI of HET Rate
CV (Percent)
of HET Rate
Sample
Size
Expected Number
of Heterozygous
Estimated 95%
CI of HET Rate
CV (Percent)
of HET Rate
0.1 N*¼10 1 0.005 ; 0.459 100.0 N¼20 2 0.018 ; 0.331 68.8
0.2 2 0.035 ; 0.558 66.7 4 0.066 ; 0.443 45.9
0.3 3 0.081 ; 0.646 50.9 6 0.128 ; 0.543 35.0
0.4 4 0.137 ; 0.726 40.8 8 0.200 ; 0.636 28.1
0.5 5 0.201 ; 0.799 33.3 10 0.279 ; 0.721 22.9
0.1 N¼50 5 0.037 ; 0.226 42.9 N¼100 10 0.052 ; 0.180 30.2
0.2 10 0.105 ; 0.341 28.6 20 0.129 ; 0.294 20.1
0.3 15 0.183 ; 0.448 21.8 30 0.215; 0.401 15.4
0.4 20 0.267 ; 0.548 17.5 40 0.305 ; 0.503 12.3
0.5 25 0.357 ; 0.643 14.3 50 0.399 ; 0.601 10.1
0.1 N¼200 20 0.064 ; 0.152 21.3 N¼500 50 0.076 ; 0.131 13.4
0.2 40 0.148 ; 0.264 14.2 100 0.166 ; 0.238 9.0
0.3 60 0.238 ; 0.369 10.8 150 0.261 ; 0.343 6.8
0.4 80 0.332 ; 0.472 8.7 200 0.357 ; 0.445 5.5
0.5 100 0.429 ; 0.571 7.1 250 0.455 ; 0.545 4.5
doi:10.1371/journal.pcbi.0030244.t001
Figure 2. Frequency Distribution of Estimated CVs of SNP HET Rates in
the dbSNP Database
The x-axis is truncated at CV . 500% for illustrative reasons even though
SNPs with higher CVs were included in the actual distribution analysis.
About 30% of SNPs have an estimated CV of  50%, less than 13% of
SNPs had an estimated CV of  20%, and less than 4% of the SNPs had a
low CV ( 5%).
doi:10.1371/journal.pcbi.0030244.g002
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SNP Heterozygosity Rates and LOH Detectioncontain at least one or more heterozygous SNPs. If all SNPs
have an identical HET rate ht (0 , ht   0.5), then k SNPs are
needed such that 1   (1   ht)
k   threshold (i.e., threshold ¼
0.95 or 0.99) to guarantee at least one or more heterozygous
SNP will be in the lost segment. However, ht is not constant
across all SNPs (Figure 1). Therefore, k SNPs are needed to
have:
1  
Y k
t¼1
ð1   htÞ threshold ð2Þ
where the threshold (i.e., threshold ¼ 0.95 or 0.99) is the
probability of having at least one or more heterozygous SNP
in the chromosome segment. Based on the distribution
pattern of HET SNP rates (Figure 1), Monte Carlo simulation
was used to estimate the number of SNPs needed (k) to satisfy
Equation 2 at the a level (i.e., 0.05 or 0.01) which guarantees
that the left-hand-side of Equation 2 will lie beyond the
threshold (1   a) 100% of the time. The probability density
distribution of k is shown in Figure 3 based on the results of
these simulations. Similarly, the simulation indicates that if
SNPs with HET rates  0.3 are randomly selected for use, then
the required number of SNPs (k) is 10, and for a SNP HET
rate  0.4, the required number of SNPs (k) is 9 (both
calculated at a ¼ 0.01 level using the cumulative density
function and threshold ¼ 0.95, unpublished data).
Given the non-random distribution pattern of SNP HET
rates in the genome, the next obvious question is how long (in
base pairs) must a random chromosomal segment be to
contain one or more heterozygous SNPs so that LOH is
detected with a high probability (e.g., 0.95 or 0.99). Based on
HapMap data, we used three approaches to ascertain this
relationship, including simulation using the ﬁtted dbSNP
HET rate distribution pattern in Figure 1, modeling of the
SNP HET rate distribution within various chromosome
deletion sizes using a negative binomial distribution (model
not shown), and random sampling along a chromosome based
on real genotyping data. The results from the three
approaches are shown in Figure 4 using Chromosomes 1, 3,
9, and 17, which frequently undergo alterations in many
cancers, as examples.
Many publications [11,18–20] have reported the mean/
median distance between SNPs (inter-SNP distance) on
speciﬁc arrays used in various studies. Therefore, we explored
the relationships between inter-SNP distances, SNP HET rate,
and detection probability of LOH to determine the chromo-
some segment size in base pairs required to have a reasonable
chance of containing an informative SNP. Let s be the size (in
nucleotide base pairs) of the DNA being lost on a
chromosome, d the distance (in nucleotide base pairs)
between two SNPs (inter-SNP distance), and hhet the SNP
HET rate, assuming the SNPs to be evenly distributed. If s   d,
the probability of the lost DNA segment containing a SNP
can be estimated as p ¼ s
d, and the probability of detecting of
LOH with HET SNPs is pd¼phhet (Figure 5A). When s . d, the
number of SNPs within the lost region is k ¼ sd = c b (bc
representing the largest integer equal to or smaller than s/d).
The probability that at least one SNP is heterozygous can be
estimated as pd¼1 (1 hhet)
k. The relationships are shown in
Figure 5.
Finally, we used a bootstrap method to randomly sample
the heterozygous SNPs on Chromosomes 1, 3, 9, and 17
genotype data within a 500 kb window in two human subjects
from the HapMap database. Figure 6 shows the spatial
distribution of LOH detection probabilities with heterozy-
gous SNPs on Chromosomes 1, 3, 9 and 17 for various loss
sizes (5 kb, 10 kb, 30 kb, and 100 kb), assuming all known SNPs
in that region were used. The mean of the detection
Table 3. Average Sample Number of Sequential Probability Ratio Test Method for SNP HET Rate Test
SNP True Het Rates (h) Power Average Sample Number (Min, Max) Probability of Accept H0 Probability of Reject H0
0.05 0.8 26(21;74) 0 1
0.9 27(22;71) 0 1
0.1 0.8 35(21;159) 0.0017 0.9983
0.9 37(22;143) 0.0004 0.9996
0.2 0.8 86(21;498) 0.1648 0.8352
0.9 99(22;498) 0.0835 0.9165
0.3 0.8 87(21;461) 0.9525 0.0475
0.9 97(22;426) 0.9507 0.0493
0.4 0.8 32(21;50) 0.9997 0.0003
0.9 42(26;67) 0.9997 0.0003
0.5 0.8 13(4;72) 1 0
0.9 17(6;95) 1 0
Each Average Sample Number was simulated with 10,000 runs. Significance level a ¼ 0.05, h0 ¼ 0.3, h1 ¼ 0.2. H0:h ¼ h0; H1:h ¼ h1,( h1 , h0).
doi:10.1371/journal.pcbi.0030244.t003
Table 2. Sample Sizes* for Testing SNP Heterozygous Rate at
Different Thresholds
Desired Low Bound of
SNP HET Rate (hr0)
Power of
Detection
hrs
0.05 0.1 0.25 0.35 0.45
0.2 0.8 32 83 419 50 19
0.9 40 109 589 72 27
 0.3 0.8 15 26 501 534 62
0.9 18 33 686 746 87
 0.4 0.8 8 13 61 583 600
0.9 10 16 83 804 834
*All sample sizes are calculated at a ¼ 0.05 level.
doi:10.1371/journal.pcbi.0030244.t002
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SNP Heterozygosity Rates and LOH Detectionprobabilities of each loss size are very similar to the results
shown in Figure 4.
Discussion
Using SNPs for LOH detection is of great value for
chromosomal instability studies and cancer risk prediction,
but a better understanding of the resolution of the technique
and how to select an informative panel of SNPs for a given
application is needed. The variances of SNP HET rates are
large for a large number of SNPs. In most cases, this is likely
to be due to the small sample sizes used for estimation of
allele frequencies in most cases. Differences in ethnic groups
might also contribute to the variance of averaged HET rates.
Relatively large sample sizes are needed to accurately
estimate SNP HET rates using traditional methods. In order
to reduce sample size for practical use, we presented two
statistical methods that could be used to determine the
number of individuals in the population that would need to
be examined to determine if a SNP HET rate was above or
below a speciﬁed threshold. The Monte Carlo simulation was
performed on SNPs in dbSNP with HET rate estimation
values  0.5 as well as all SNPs, with essentially no change in
the conclusion of the study (Figure 3). Only 0.2% of the SNPs
in dbSNP have a HET rate estimation higher than 0.5, some of
which may be truly higher due to violations of Hardy-
Weinberg equilibrium and some due to other factors such as
estimation from a small sample size.
Based on speciﬁc study goals or technologies, more study
speciﬁc methods such as truncated SPRT schemes [17] could
potentially be used to minimize the sample size when the
HET rate is close to the testing rate. In addition, since
different human populations (e.g., Asian versus African
versus European) may have different SNP distribution
patterns [21–23], the sample size calculation methods may
only be applicable within speciﬁc populations instead of
across mixed populations. Finally, although the SNP HET
rates could be inferred using linkage disequilibrium infor-
mation (i.e., pair-wise linkage disequilibrium r
2), the estima-
tion of r
2 and variance of r
2 themselves are subject to the
effects of sample size and evolutionary history of speciﬁc
SNPs [24]. Therefore, the sample size and variance of r
2
should be considered when r
2 are used for inferring SNP HET
rates if a study has stringent requirements (i.e., development
of clinical diagnostic markers).
We did not distinguish coding and non-coding regions of
the genome in this simulation since Cargill et al. [5] reported
that there is no signiﬁcant difference in SNP density between
coding and non-coding regions, and since the breakpoints of
chromosome loss are poorly understood. We also examined
the detection probability of LOH due to various sizes of
chromosome loss assuming all known SNPs were used. This
question is closely related to sample size and statistical power
calculation in the experimental design for a neoplastic
progression study; e.g., a small segment of chromosome loss
has a lower detection probability for LOH, and in order to
detect it, large sample sizes are needed. We also veriﬁed the
simulation results directly using the SNP genotype data (all
SNPs were used) from 90 individual subjects from the
HapMap database (Figure 4, red line). The detection
probabilities based on simulation methods are reasonably
Figure 3. Probability Density Function (Bars) and Cumulative Density (Lines) of the Number of SNPs Needed To Have at Least One Heterozygous SNP
Based on Simulation Results Using the Distribution Shown in Figure 1
At a¼0.01 level, (A) and (C) are for left-hand side of Equation 2   0.95; (B) and (D) for   0.99, respectively. (A,B) Are the results of excluding SNPs with
HET rates . 0.5. (C,D) Are the results without the exclusion. The required number of SNPs ki can be estimated based on the cumulative density
distribution function (cdf): [1  P(k   ki)]  a. The simulation shows that if SNPs were randomly used for LOH detection, then ki ¼ 15 for threshold ¼
0.95; and ki ¼ 20 for threshold ¼ 0.99 (both were calculated at a ¼ 0.01 level for cdf).
doi:10.1371/journal.pcbi.0030244.g003
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SNP Heterozygosity Rates and LOH Detectionclose to the observed data, but may be overly optimistic to a
certain degree. Such differences may be due to bias in the
SNP HET rate estimation distribution [25] toward common
SNPs (Figure 1) or to a non-random distribution of SNPs.
Our study showed that a region of LOH greater than 200 kb
could be detected with high probability (.90%), with losses
smaller than 50 kb having a substantially lower detection
probability when using all SNPs currently in the HapMap
database (Figure 4). Higher densities of SNPs exist in certain
chromosomal regions that provide the opportunity for
reliably (p . 0.95 or 0.99) detecting LOH of segment sizes
smaller than 50 kb (Figure 6). Finally, we evaluated the LOH
detection probability for the given inter-SNP distances as
reported for many commercial products (e.g., SNP-based
genotyping arrays) or in published studies. For inter-SNP
distances of 120 kb to 200 kb, the probability of detecting
LOH for LOH of 300 kb or smaller ranges from 20% to 60%
depending on SNP HET rates. The detection probability
appears close to 1 if the region of loss is 900 kb or larger. The
detection probabilities with inter-SNP distances 120 or 200
kb indicated in Figure 5 are substantially lower than the
results shown in Figure 4 for a similar size of LOH. This is
because the results in Figure 4 assume all SNPs currently
reported in HapMap were used, whereas for Figure 5, SNPs
with ﬁxed inter-SNP distances (fewer SNPs) were used to
calculate the detection probabilities. To increase detection
probability, more SNPs should be used, or inter-SNP distance
should be minimized (red line in Figure 5); however, this
might be limited by the actual number of HET SNPs in a
given chromosome segment. An alternate solution would be
to increase sample size (statistical power) to detect small size
of loss in an experiment. To a certain degree, improvements
in LOH detection algorithms will increase the LOH detection
probability. Improvements might include increasing the
sensitivity of LOH detection in mixed cell populations (i.e.,
the neoplastic changes in somatic tissue). Combining copy
number measurements and allele ratio measurements will
increase detection of deletions but not copy neutral LOH.
However, the resolution of LOH will still be constrained by
the informative SNP distribution pattern itself. Sequencing
or screening more human subjects to ﬁnd more new SNPs
could improve the theoretical detection probability as shown
in Figures 4 and 6 only if the future-discovered SNPs are of
great abundance and have high HET rates. For example, a
SNP chip with 1 million SNPs to cover the 3 billion bp human
genome would have a 3 kb mean inter-SNP distance. If the
Figure 4. Relationship between Size of Chromosome Loss (kb) and Probability of Detection of LOH Assuming Use of All Chromosome 1, 3, 9, and 17
SNPs in HapMap
Blue and black lines are the simulated results using HET rate distribution pattern in dbSNP (Figure 1) with the assumptions of successful detection if k¼
15 (95%) or 20 (99%) SNPs per lost segment as shown in Equation 2. Red lines represent the probability of detection of LOH using HET SNPs based on
real genotype data of 90 patients in the CEU group of the HapMap. Magenta lines represent the probability of LOH detection based on fitted model
(HET SNP distribution was fitted with negative binomial distribution) prediction. The simulation results indicated a detection probability of about 75%–
85% for 30 kb loss size (blue, black); the probability of detection reaches 95% or higher when loss size is approximately 50 ; 60 kb or larger. The LOH
size approximately has to be 250 kb or larger in order to achieve a 99% or higher detection probability (except for Chromosome 9 with slightly lower
probability values). The results based on real genotyping data (red line) indicate a detection probability of about 70% for a 30 kb loss size; the
probability of detection reaches 95% or higher when loss size is approximately 200 kb or larger, and the loss size has to be 450 kb or larger in order to
achieve a 99% detection probability. The results based on model fitting (magenta lines) appear to be a good approximation of the results based on
genotyping data (red lines).
doi:10.1371/journal.pcbi.0030244.g004
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maximize coverage, the regions of LOH would need to be
32kb or larger in order to be detected with 0.95 probability
assuming a SNP HET rate of 0.25 (and 26kb or larger for a
HET rate of 0.3). Due to uneven distribution of SNPs in actual
sequences, the detection probability will ﬂuctuate with
similar patterns shown in Figure 6.
Using dbSNP and HapMap data, this study evaluated the
distribution of SNP HET rates and resolution of LOH
genome wide. The results of this study have two important
implications that might improve design and interpretation of
future genome wide LOH screens of cancers and premalig-
nant tissues. First, retrospective review of previous genome-
wide LOH screens indicate that technology limitations (i.e.,
SNP density of arrays) used in the experiments could have
missed signiﬁcant numbers of LOH events that were below
the resolution of the SNP array [26–31]. By using the analysis
methods reported in this paper, reports of genome wide LOH
could discuss the limitations of the resolution of the study in
terms of what might have been missed in addition to the
important loci that were discovered. A well-designed study
using carefully selected SNP sets for evaluating speciﬁc
regions on several chromosomes still had more than 280 kb
distance on average between two informative SNPs [32].
However, in general, 280 kb is still relatively large considering
an average gene size is 3 to 20 kb in the human genome, and
smaller regions of LOH (i.e., ,50 kb) might still be important,
especially for early stages of neoplastic progression. The
characteristics of LOH resolution mentioned above still apply
to higher-density SNP arrays.
LOH has been frequently proposed as a candidate
biomarker for cancer risk prediction. The ability to detect
an LOH event will depend on informativity, SNP density, and
the size of the LOH event. Our results could improve sample
size calculations for design of future LOH studies. If one
would like to detect the effect of an LOH event on the risk of
progression to cancer, then the sample size depends on the
LOH detection probability. For example, in a study with a 1:5
ratio of cases and controls, a minimum detectable relative
risk of the LOH of 5, a statistical detection power 0.9, and an
LOH prevalence rate of 30% among informative subjects, at
least 23 cases and 117 controls will be needed if the LOH
detection probability is 100% (large region loss or high
density of informative SNPs). However, if the LOH detection
probability is 0.7 or 0.3, for example, (e.g., a smaller loss event,
or fewer informative SNPs), then at least 44 cases and 190
controls or 116 cases and 468 controls will be needed,
respectively.
All the results obtained in this analysis are based on the
assumption that heterozygous SNPs are required for detec-
tion of LOH. New technologies are emerging that could be
used to detect chromosome copy number changes (including
deletion) using homozygous SNPs with a reasonably high
accuracy [33,34]. However, since LOH can result from
mechanisms that do not change copy number [35,36], using
copy number approaches can only yield a partial picture of
Figure 5. Relationship among Inter-SNP Distance, Size of LOH, and Probability of Detection of LOH with Heterozygous SNPs, Assuming an Even
Distribution of SNPs
(Red lines: inter-SNP distance ¼ 12kb; green lines: inter-SNP distance ¼ 120kb; blue lines: inter-SNP distance ¼ 200 kb). For each color, the three lines
from bottom to top correspond to SNP HET rates of 0.2 (bottom), 0.3 (middle), and 0.4 (top).
(A) Shows the results when the chromosomal region being lost is smaller than the inter-SNP distance. For example, with a 100 kb region being lost and
a 200 kb inter-SNP distance, the LOH detection probabilities are 8%, 15%, and 20% for 0.2, 0.3, and 0.4 SNP HET rates, respectively, (blue lines). The
maximum detection probability is about 40% or less, depending on SNP HET rate.
(B) Shows the results when the region of loss size is larger than the inter-SNP distance. For a 300 kb region of loss size and a 120 kb inter-SNP distance,
the detection probability is about 40%, 60%, and 70% for SNP HET rates of 0.2, 0.3, and 0.4, respectively, in the calculation (green lines). As the regiono f
loss increases, approaching 900 kb, the LOH detection probability will approach 0.9 or higher when the SNPs have a HET rate of 0.3 or higher. Similarly,
with a 200 kb inter-SNP distance and a region of loss of 300 kb, the probabilities of detection of LOH are about 28%, 40%, and 52% for SNP HET rates of
0.2, 0.3, and 0.4, respectively (blue lines). If the inter-SNP distance is 12 kb, the detection probability of LOH is fairly high (more than 85%) when loss size
is about 100 kb or longer (red lines). The results were based on the assumption that the SNPs selected and arrayed on the chips are evenly distributed
on the chromosome, which gives the most optimistic detection probability for genome-wide screening. If the selected SNPs on a chip are not evenly
distributed, the detection probability will be reduced. If all the current available SNPs are used (arrayed on a chip), the detection probabilities become
the pattern as shown in Figure 4.
doi:10.1371/journal.pcbi.0030244.g005
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SNP Heterozygosity Rates and LOH Detectionthe LOH status of a region of interest. Combining the
analyses presented in this study and copy number could lead
to a high level of reliability and a higher resolution in LOH
detection for neoplastic progression research and biomarker
development.
Methods
Data. The data for SNPs HET rates were downloaded from dbSNP
(build 126) (ftp://ftp.ncbi.nih.gov/snp/organisms/human_9606/
database/organism_data/). HapMap SNP data for the human genome
were downloaded from the HapMap Web site (July 2006 release)
(http://www.hapmap.org/genotypes/). We only used the CEU popula-
tion (Utah residents with Northern and Western European ancestry)
data from HapMap. Our methods can easily be extended to other
ethnic group data. The estimated SNP HET rates .0.5 were dropped
from the analysis of HET rate distribution. The estimated variances
for SNP HET rates were directly obtain from dbSNP.
Simulation. Data from dbSNP were used to summarize the HET
rate distribution pattern of SNPs (Figure 1) and evaluate the
estimated variances of HET rates in dbSNP (Figure 2). To estimate
the number of SNPs needed for LOH detection in any given
chromosomal region, a Monte Carlo simulation method was used.
In this process, a SNP was selected and the determination of its
heterozygosity was based upon the HET SNP distribution shown in
Figure 1. This process was repeated until the cumulative probability
of HET SNP reached the threshold at a predetermined a level (i.e., a¼
0.05 or 0.01) which guarantees that the left-hand-side of Equation 2
will lie beyond the threshold (1 a) 100% of the time (Figure 3). The
simulation for chromosome segment deletion (Figure 4) was done
using the genotype data from the HapMap CEU population data. In
the simulation process, for each of the Chromosomes 1, 3, 9, 13, 17,
and 18 (results of Chromosome 13 and 18 are unpublished data), a
random segment was removed from the chromosome (mimicking the
region of LOH on a chromosome), and the number of SNPs in the
region was examined based on the genotype data of the individuals.
The process was repeated 20,000 times for each segment size on a
chromosome. The segment sizes of loss used in the simulation are: 5,
10, 20, 30, 50, 100, 200, 300, 500, 1,000, 2,000, 3,000, 4,000, and 5,000
kb. Based on these data, three methods (negative binomial model
ﬁtting, Monte Carlo simulation, and bootstrap) were used to
investigate the relationship between the size of chromosome loss
and probability of LOH detection. For negative binomial model
ﬁtting, which was found to ﬁt the data best among the various
theoretical distributions we evaluated, the discrete frequency
distribution patterns of HET SNPs for each segment size listed above
were ﬁtted to a negative binomial model. Speciﬁcally, for the data of
each segment size of loss, the HET SNP counts in each sample along a
chromosome were used to estimate the parameters of negative
binomial distribution with maximum likelihood method. The random
numbers of HET SNPs were then generated based on the ﬁtted
negative binomial distribution parameters for each size of segment
loss. This was repeated 10,000 times for each segment size and the
detection probabilities were calculated based on the process for each
segment (Figure 4, magenta lines). For the Monte Carlo simulation
(Figure 4, blue and black lines), for each size of deletion listed above,
the number of SNPs for each segment was counted, and the number
of HET SNPs and detection probabilities were determined based on
the empirical distribution pattern shown in Figure 1. For the
bootstrap method, the observed detection probability (Figure 4 red
line) was obtained by directly counting the HET SNPs in each
segment based on the real genotyping data in the bootstrap sampling
process. The results in Figure 5 were obtained by the probability
model described in the text.
To examine the spatial pattern of LOH detection probability along
a chromosome (Figure 6), we chose the 500 kb window size along
Chromosomes 1, 3, 9, and 17, and within each window samples were
randomly taken with various loss sizes to calculate the probabilities of
LOH detection within each window along the chromosome. Similar
patterns were found on other chromosomes (unpublished data). All
analyses and simulations were carried out with Matlab (version 7.1,
The MathWorks).
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